Single Molecule Analysis Group, Department of Chemistry, University of Michigan, Ann Arbor, Michigan, 48109, United States.
aLight Sciences, Inc., 333 Jackson Plaza Suite 460, Ann Arbor, Michigan, 48103, United States.
Biosens Bioelectron. 2022 Nov 15;216:114639. doi: 10.1016/j.bios.2022.114639. Epub 2022 Aug 22.
Sensitive assays of protein biomarkers play critical roles in clinical diagnostics and biomedical research. Such assays typically employ immunoreagents such as monoclonal antibodies that suffer from several drawbacks, including relatively tedious production, significant batch-to-batch variability, and challenges in site-specific, stoichiometric modification with fluorophores or other labels. One proposed alternative to such immunoreagents, nucleic acid aptamers generated by systematic evolution of ligand by exponential enrichment (SELEX), can be chemically synthesized with much greater ease, precision, and reproducibility than antibodies. However, most aptamers exhibit relatively poor affinity, yielding low sensitivity in the assays employing them. Recently, single molecule recognition through equilibrium Poisson sampling (SiMREPS) has emerged as a platform for detecting proteins and other biomarkers with high sensitivity without requiring high-affinity detection probes. In this manuscript, we demonstrate the applicability and advantages of aptamers as detection probes in SiMREPS as applied to two clinically relevant biomarkers, VEGF and IL-8, using a wash-free protocol with limits of detection in the low femtomolar range (3-9 fM). We show that the kinetics of existing RNA aptamers can be rationally optimized for use as SiMREPS detection probes by mutating a single nucleotide in the conserved binding region or by shortening the aptamer sequence. Finally, we demonstrate the detection of endogenous IL-8 from human serum at a concentration below the detection limit of commercial ELISAs.
蛋白质生物标志物的灵敏检测在临床诊断和生物医学研究中起着至关重要的作用。此类检测通常采用单克隆抗体等免疫试剂,但这些试剂存在几个缺点,包括生产过程相对繁琐、批次间差异较大,以及在荧光团或其他标签的定点、化学计量修饰方面存在挑战。作为免疫试剂的一种替代方法,通过指数富集的配体系统进化(SELEX)生成的核酸适体,可以比抗体更容易、更精确、更可重复地进行化学合成。然而,大多数适体的亲和力相对较差,导致使用它们的检测灵敏度较低。最近,通过平衡泊松采样的单分子识别(SiMREPS)作为一种高灵敏度检测蛋白质和其他生物标志物的平台出现,而不需要高亲和力的检测探针。在本文中,我们通过无洗涤协议(检测限在低飞摩尔范围内(3-9 fM)),展示了适体作为 SiMREPS 检测探针的适用性和优势,该协议适用于两种临床相关的生物标志物,VEGF 和 IL-8。我们表明,可以通过突变保守结合区域中的单个核苷酸或缩短适体序列,对现有 RNA 适体的动力学进行合理优化,以用作 SiMREPS 检测探针。最后,我们证明了可以在商业 ELISA 的检测限以下检测人血清中的内源性 IL-8。